PATENT CLAIM ANALYSIS

Application Number: 16115969
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["514", "019400"]

Abstract:
The invention provides an isolated or purified T cell receptor (TCR) having antigenic specificity for NY-ESO-1. Also provided are related polypeptides, proteins, nucleic acids, recombinant expression vectors, isolated host cells, populations of cells, antibodies, or antigen binding portions thereof, and pharmaceutical compositions. The invention further provides a method of detecting the presence of cancer in a mammal and a method of treating or preventing cancer in a mammal using the inventive TCRs or related materials.

Claim (Index 42):
The method of  claim 28 , wherein the cancer is breast cancer.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 96.0
- Lexical Diversity: 1.51724
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15267285', '14401893', '14427671', '15848344', '12443111']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7662305637797003
- 35 USC 102 Novelty (BERT): 0.5510101536657096
- Combined Prediction Score: 0.7447085227683012
- Mean Citation Score: 317.24821000000014
- Max Citation Score: 395.32495
- Similarity Product: 309.92520959695577

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test